𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic Factors for Sporadic Medullary Thyroid Carcinoma

✍ Scribed by Kaptan Gülben; Uğur Berberoğlu; Mustafa Boyabatlı

Publisher
Springer
Year
2005
Tongue
English
Weight
124 KB
Volume
30
Category
Article
ISSN
0364-2313

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD15 (LeuM1) immunoreactivity: Prognosti
CD15 (LeuM1) immunoreactivity: Prognostic factor for sporadic and hereditary medullary thyroid cancer?
✍ Friedrich Längle; Thomas Soliman; Nikolaus Neuhold; Gerold Widhalm; Bruno Nieder 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 494 KB

Patients treated for sporadic and hereditary medullary thyroid carcinoma (MTC) have varying rates of persistent disease, recurrence, and survival. The aim of this study was to correlate the immunoreactivity of the monoclonal antibody CD15 (LeuM1) to initial clinical findings and the outcome of treat

Mutation of the RET protooncogene in spo
Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma
✍ Charis Eng; Lois M. Mulligan; Darrin P. Smith; Catherine S. Healey; Andrea Frill 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

Medullary thyroid carcinoma (MTC) occurs sporadically or as part of the inherited cancer syndrome multiple endocrine neoplasia (MEN) type 2. In MEN 2A, germline missense mutations are found in one of five cysteine codons within exons 10 and I I in the extracellular domain of the RET protooncogene. I